- Clinical AI technology company Sensyne Health said it would consult with its major shareholders after it awarded bonuses to its chief executive and chief financial officer that an adviser warned could upset the market.

The company also said that chairman Charles Swingland was recovering from a recent illness, which may take a number of weeks. Current director Annalisa Jenkins had been appointed as acting chair.

The company's CEO, Lord Drayson, and CFO, Lorrie Headley, were paid post-IPO bonuses of £850k and £200k, respectively.

Sensyne Health said that although it had received a preliminary view from adviser Peel Hunt of a 'likely unfavourable market reaction' to the payments, it did not discuss them further with Peel Hunt.

Peel Hunt was recently made aware of the payments and had advised the company that they constituted related-party transactions under listing rules.

'The directors considered the payments to be appropriate and remain of that view,' Sensyne Health said.

'Peel Hunt cannot advise as to whether the payments were fair and reasonable.'

'The company intends to consult with its major institutional shareholders on the payments and its remuneration policy following the publication of its annual report on 7 October 2019.' Story provided by